Structure Free AI-Powered Drug Design Biotech Company

We, Deargen, maximizes the efficiency of new drug development by using an advanced Artificial Intelligence (A.I). We help to deliver and provide greater treatment to patient.

DearTRANS

Genome data Analysis

WX

Biomarker Prediction

AI-Powered

Target Discovery

DearDTI

Molecule Selection

MolEQ

Lead Optimization

AI-Powered

Drug Design

The AI Platform For Drug Discovery

Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.

Our Technology Dr.UG

Pipeline

What we can do is...

Deargen’s A.I technology is being applied to various new drug development treatment strategies.

Learn More Our Pipeline

PROTAC

ADC

EPITOPE

AGONIST

INHIBITOR

Our Team

We make it together

We realize Precision Medicine together with experts in Deep learning, Software, Biology and Bioinformatics. Our brilliant Avengers team acts faster than anyone else and consistently moves to face new challenges.

Meet Our Teams

"Let's make a together"

Kilsoo Kang / CEO

Partners

Corporate Partnership

Scientific Collaboration

Contact

Email

contact@deargen.me

Phone

+82 (0)43 716 2100

FAX

+82 (0)43 716 2101

Address

Daejeon Office

6F, A602, Administration B/D, 193, Munji-ro, Yuseong-gu, Daejeon, Republic of Korea

Seoul Office (Research Institute)

Deargen, 15th floor, Dongwon F&B, 60, Mabang-ro, Seocho-gu, Seoul, Republic of Korea

KOR
EN

ⓒ 2021 Deargen Inc.